Astatine-211: Endogenous alpha-radiotherapy for thyroid cancer

被引：0
|
作者：
Brown, I
Randle, K
机构：
来源：
IMMUNODEFICIENT ANIMALS: MODELS FOR CANCER RESEARCH | 1996年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：161 / 165
页数：5
相关论文
共 50 条
  • [1] ABSOLUTE ALPHA COUNTING OF ASTATINE-211
    BASSON, JK
    ANALYTICAL CHEMISTRY, 1956, 28 (09) : 1472 - 1474
  • [2] ANAPLASTIC THYROID-CANCER - PRELIMINARY STUDIES WITH ASTATINE-211
    BROWN, I
    CARPENTER, RN
    CLINICAL RADIOLOGY, 1988, 39 (03) : 353 - 353
  • [3] ASTATINE-211 IN CANCER-THERAPY
    COBB, LM
    BRITISH JOURNAL OF CANCER, 1989, 59 (05) : 819 - 819
  • [4] Production and assessment of astatine-211 for targeted alpha therapy
    Crawford, J.
    Beckham, W.
    Jirasek, A.
    Ruth, T.
    MEDICAL PHYSICS, 2012, 39 (07) : 4627 - 4627
  • [5] Astatine-211 imaging by a Compton camera for targeted radiotherapy
    Nagao, Yuto
    Yamaguchi, Mitsutaka
    Watanabe, Shigeki
    Ishioka, Noriko S.
    Kawachi, Naoki
    Watabe, Hiroshi
    APPLIED RADIATION AND ISOTOPES, 2018, 139 : 238 - 243
  • [6] Pretargeted Alpha Therapy of Disseminated Cancer - Combining Click Chemistry and Astatine-211
    Timperanza, Chiara
    Lindegren, Sture
    Aneheim, Emma
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S259 - S260
  • [7] Astatine-211: Production and Availability
    Zalutsky, Michael R.
    Pruszynski, Marek
    CURRENT RADIOPHARMACEUTICALS, 2011, 4 (03) : 177 - 185
  • [8] An astatine-211 labeled PSMA inhibitor for targeted alpha-particle radiotherapy of prostate carcinoma
    Vaidyanathan, Ganesan
    Mease, Ronnie
    Affleck, Donna
    Chen, Ying
    Welsh, Philip
    Hens, Marc
    Pomper, Martin
    Zalutsky, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [9] NUCLEAR SPIN OF ASTATINE-211
    GARVIN, HL
    GREEN, TM
    LIPWORTH, E
    NIERENBERG, WA
    PHYSICAL REVIEW LETTERS, 1958, 1 (02) : 74 - 75
  • [10] TOXICITY OF ASTATINE-211 IN THE MOUSE
    COBB, LM
    HARRISON, A
    BUTLER, SA
    HUMAN TOXICOLOGY, 1988, 7 (06): : 529 - 534
12345